FPN || Men's Health

International study characterizes male breast cancer

Posted on: 23/12/2014 - 17:19

SAN ANTONIO – Male breast cancers share some important characteristics with female breast cancers: The tumors found in males are usually hormone receptor positive and of luminal A subtype, and...

Field of Interest: Oncology

Type: News Item

High serum vitamin D levels linked to prostate cancer risk

Posted on: 18/12/2014 - 20:07

Mounting evidence suggests that there may be an increased risk of prostate cancer among men with the highest levels of vitamin D. At a public conference on vitamin D sponsored by the National...

Field of Interest: Oncology

Type: News Item

Prostate cancer surveillance appears safe through 15 years

Posted on: 15/12/2014 - 21:00

Active surveillance appears to be safe through 15 years of follow-up for men who have low-risk prostate cancer, according to a report published online Dec. 15 in the Journal of Clinical Oncology. In...

Field of Interest: Oncology

Type: News Item

No increase in prostate cancer with testosterone therapy

Posted on: 05/12/2014 - 13:36

A study of hypogonadal men undergoing testosterone therapy has found a lower rate of prostate cancer than previously recorded in screening studies, suggesting the therapy does not increase prostate...

Field of Interest: Oncology

Type: News Item

Men on androgen deprivation therapy not getting bisphosphonates

Posted on: 02/12/2014 - 21:00

The rate of prescribing bisphosphonates to protect the bone health of prostate cancer patients taking androgen deprivation therapy is extremely low in Ontario, even among those at high risk of...

Field of Interest: Oncology

Type: News Item

Has advertising for prostate cancer treatment gone too far?

Posted on: 14/11/2014 - 16:43

Dr. Benjamin Davies has responded to advertising claims that recently ran in the Sunday New York Times Magazine and the New Yorker with an article in Forbes entitled “Prostate Cancer Advertising:...

Field of Interest: Oncology

Type: News Item

Adding abiraterone improves suppression of intraprostate androgens

Posted on: 13/10/2014 - 21:24

Adding abiraterone to standard neoadjuvant therapy using luteinizing hormone-releasing hormone agonists induces markedly more effective androgen suppression within the prostate tissue in men who have...

Field of Interest: Oncology

Type: News Item

Hypofractionation, vessel-sparing RT techniques for prostate cancer yield good QOL

Posted on: 10/10/2014 - 16:32

SAN FRANCISCO – Use of a shorter, more convenient course of radiation therapy for prostate cancer or a technique that spares blood vessels critical for sexual function yields good long-term quality...

Field of Interest: Oncology

Type: News Item

Specific pattern of male pattern baldness linked to aggressive prostate cancer

Posted on: 24/09/2014 - 15:55

Men with a combination of frontal and moderate vertex baldness at age 45 were at a significantly increased risk of having aggressive prostate cancer in a large prospective cohort study, according to...

Field of Interest: Oncology

Type: News Item

FDA panel recommends against approval of ultrasound therapy for early prostate cancer

Posted on: 31/07/2014 - 16:30

GAITHERSBURG, MD. – A Food and Drug Administration advisory panel agreed that a device that thermally ablates the prostate gland using high-intensity focused ultrasound should not be approved for...

Field of Interest: Oncology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters